Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Entyvio (Vedolizumab) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Dec.
OVERVIEW | |
---|---|
Interface: | Ovid |
Databases: | Embase 1974 to present MEDLINE Daily and MEDLINE 1946 to present MEDLINE Epub Ahead of Print, In-Process & Other Non-Indexed Citations Note: Subject headings have been customized for each database. Duplicates between databases were removed in Ovid. |
Date of Search: | May 19, 2016 |
Alerts: | Biweekly search updates until September 21, 2016 |
Study Types: | No search filters were applied |
Limits: | No date or language limits were used Conference abstracts were excluded |
SYNTAX GUIDE | |
/ | At the end of a phrase, searches the phrase as a subject heading |
Mh | Medical Subject Heading |
exp | Explode a subject heading |
* | Before a word, indicates that the marked subject heading is a primary topic; or, after a word, a truncation symbol (wildcard) to retrieve plurals or varying endings |
.ti | Title |
.ab | Abstract |
.ot | Original title |
.hw | Heading word; usually includes subject headings and controlled vocabulary |
.kf | Author keyword heading word (MEDLINE) |
.kw | Author keyword (Embase) |
.rn | CAS registry number |
.nm | Name of substance word |
ppez | Ovid database code; MEDLINE Epub Ahead of Print, In-Process & Other Non-Indexed Citations, MEDLINE Daily and Ovid MEDLINE 1946 to Present |
oemezd | Ovid database code; Embase 1974 to present, updated daily |
MULTI-DATABASE STRATEGY | ||
---|---|---|
Line # | Search strategy | Results |
1 | (Entyvio* or vedolizumab* or LDP02 or "LDP 02" or MLN0002 or "MLN 0002" or MLN02 or "MLN 02" or 943609-66-3 or 9RV78Q2002).ti,ab,ot,kf,hw,rn,nm. | 1076 |
2 | 1 use ppez | 224 |
3 | *vedolizumab/ or (vedolizumab* or LDP02 or "LDP 02" or MLN0002 or "MLN 0002" or MLN02 or "MLN 02" or 943609-66-3 or 9RV78Q2002).ti,ab,kw. | 641 |
4 | 3 use oemezd | 442 |
5 | 4 not conference abstract.pt. | 246 |
6 | 2 or 5 | 470 |
7 | remove duplicates from 6 | 301 |
OTHER DATABASES | |
---|---|
PubMed | A limited PubMed search was performed to capture records not found in MEDLINE. Same MeSH, keywords, limits, and study types used as per MEDLINE search, with appropriate syntax used. |
Trial registries (Clinicaltrials | Keywords used: Entyvio/vedolizumab and Crohn’s disease |
Grey Literature
Dates for Search: | May 18-19, 2016 |
Keywords: | Entyvio, vedolizumab, Crohn’s disease |
Limits: | No date or language limits used |
Relevant websites from the following sections of the CADTH grey literature checklist, Grey Matters: a practical tool for searching health-related grey literature (https://www.cadth.ca/grey-matters), were searched:
- Health Technology Assessment Agencies
- Health Economics
- Clinical Practice Guidelines
- Drug and Device Regulatory Approvals
- Advisories and Warnings
- Drug Class Reviews
- Databases (free)
- Internet Search
- LITERATURE SEARCH STRATEGY - Entyvio (Vedolizumab)LITERATURE SEARCH STRATEGY - Entyvio (Vedolizumab)
Your browsing activity is empty.
Activity recording is turned off.
See more...